MedTrace Logo

Tolerability and Safety of An Infant Formula

NCT00938483 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2009-07-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate an extensively hydrolyzed formula in infants with cow's milk allergy.

Conditions

  • Milk Hypersensitivity

Interventions

OTHER

Nutramigen Lipil (Infant formula)

Sponsors & Collaborators

  • Perrigo Nutritionals

    lead INDUSTRY

Principal Investigators

  • Cynthia M Barber, PhD · Perrigo Nutritionals

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
12 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2008-09-30
Completion
2009-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00938483 on ClinicalTrials.gov